Department of Obstetrics and Gynecology

Department of Reproductive Genetics

Articles, Patents and Intellectual Property

Brady TB, Kramer RL, Qureshi F, Feldman B, Kupsky WJ, Johnson MP, Evans MI. Ontogeny of recurrent hydrocephalus: Presentation in three fetuses in one consanguineous family. Fetal Diagnosis and Therapy 14(4):198-200, 1999.

Brooks K, Chik L, OÕBrien JE, Critchfield G, Ayoub M, Johnson MP, Evans MI. Variability of adjustments to indecies in determining risk in biochemical screening. Fetal Diagnosis and Therapy 14(1):41-46, 1999.

Carreno C, King M, Johnson MP, Yaron Y, Diamond M, Bush D, Evans MI. Treatment of heterotopic cervical and intrauterine pregnancy. Fetal Diagnosis and Therapy (in press).

Chong S, Almqvist E, Telenius H, Bourdelat-Parks B, Hughes MR, Hayden MR. DNA sequence and (CAG) size are major factors influencing instability of the Huntington disease gene: evidence from single sperm analysis of intermediate alleles. Human Molecular Genetics (in press).

Chong S, Gore-Langton R, Hughes MR. Single-cell molecular analysis: Application to Preimplantation Diagnosis. Current Protocols in Human Genetics (in press).

Drugan A, Bronstein M, Itskovitz-Eldor J, Johnson MP, Evans MI. Ontogeny of isolated ultrasound markers for fetal aneuploidy. Fetal Diagnosis and Therapy 14(5):266-269, 1999.

Drugan A, Johnson MP, Evans MI. Ultrasound screening for fetal chromosome anomalies. American Journal of Medical Genetics (in press).

Drugan A, Yaron Y, Zamir R, Ebrahim SAD, Johnson MP, Evans MI. Differential effect of advanced maternal age on prenatal diagnosis of trisomy 13, 18, and 21. Fetal Diagnosis and Therapy 14(3):181-184, 1999.

Evans MI, Berkowitz R, Wapner R, Carpenter R, Goldberg J, Ayoub MA, Horenstein J, Dommergues M, Brambati B, Nicolaides K, Holzgreve W, Timor-Tritsch IE,. Multifetal pregnancy reduction (MFPR): Improved outcomes with increased experience. American Journal of Obstretrics and Gynecology (in press).

Evans MI, Goldberg J, Horenstein J, Wapner R, Ayoub MA, Stone J, Lipitz S, Achiron R, Holzgreve W, Brambati B, Johnson A, Johnson MP, Berkowitz R. Selective termination (ST) for structural (STR), chromosomal CHR), and Mendelian (MEN) anomalies: International experience. American Journal of Obstetrics and Gynecology 181(4):893-897, 1999.

Evans MI, Henry GP, Miller WA, Bui TH, Snidjers RJ, Wapner RJ, Miny P, Johnson MP, Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim SAD, Babu R, Jackson L. International, collaborative assessment of 146,000 prenatal karyotypes: Expected limitations if only chromosome-specific probes and fluorescent in situ hybridization were used. Human Reproduction 14(5):1213-16, 1999.

Feldman B, Hassan S, Kramer RL, Kasperski SB, Evans MI, Johnson MP. Amnioinfusion in the evaluation of fetal obstructive uropathy: The effect of antibiotic prophylaxis on complication rates. Fetal Diagnosis and Therapy 14(3):172-175, 1999.

Feldman B, Ebrahim SAD, Gyi K, Flore LA, Evans MI. Rapid confirmation of previously detected prenatal mosaicism by fluorescence in situ hybridization in interphase uncultured amniocytes. Genetic Testing (in press).

Feldman B, Ebrahim SAD, Hazan SL, Gyi K, Johnson MP, Johnson A, Evans MI. Routine prenatal diagnosis of aneuploidy by FISH studies in high risk pregnancies. American Journal of Medical Genetics (in press).

Feldman B, Yaron Y, Ayoub M, Critchfield G, Dombrowski MP, Leon J, OÕBrien JE, Evans MI. Distribution of neural tube defects and risks as a function of maternal weight: No apparent correlation. Fetal Diagnosis and Therapy 14(3)185-189, 1999.

Freedman AL, Smith CA, Evans MI, Gonzalez R, Johnson MP. Long term outcome in children following antenatal intervention for obstructive uropathies. Lancet 354(9176):374-377, 1999.

Haddad B, Subramanian S, Chong S, Hughes MR. Molecular genotyping of single cells. Human Molecular Reproduction (in press).

Miller V, Ransom SB, Ayoub MA, Krivchenia EL, Evans MI. The fiscal impact of a potential legislative ban on second trimester for prenatally diagnosed abnormalities. American Journal of Medical Genetics (in press).

Miller VL, Ransom SB, Shalhoub A, Sokol RJ, Evans MI. Multifetal Pregnancy Reduction: Perinatal and Fiscal Outcomes. American Journal of Obstetrics and Gynecology (in press).

Pryde P, Hallak M, Lauria M, Littman L, Bottoms S, Johnson M, Evans MI. Severe oligohydramnios with intact membranes: An indication for diagnostic amnioinfusion. Fetal Diagnosis and Therapy (in press).

Quintero RA, Johnson MP, Mendoza G, Evans MI. The ontogeny of clenched hand development in trisomy-18 fetuses: A serial transabdominal fetoscopic observation. Fetal Diagnosis and Therapy 14:68-70, 1999.

Qureshi F, Jacques SM, Feldman B, Doss BJ, Johnson A, Evans MI, Johnson MP. Fetal obstructive uropathy in trisomy syndromes. Fetal Diagnosis and Therapy (in press).

Ransom SB, Mickelson IH, Makela PR, Essenmacher L, Evans MI. The quality of cost-effectiveness and cost-benefit analyses in the obstetrics and gynecology literature. American Journal of Obstetrics and Gynecology (in press).

Seubert DE, Feldman B, Krivchenia EL, Evans MI, Barki J, Johnson MP. Molecular and fetal tissue biopsy capabilities are needed to maximize prenatal diangosis of junctional epidermolysis bullosa (JEB): Fetal skin biopsy using a 2mm microendoscope. Fetal Diagnosis and Therapy (in press).

Stewart K, Kramer RL, Evans MI, Krawetz SA. Temporal expression of the transgenic human protameine gene cluster. Fertility and Sterility 71(4):739-45, 1999.

Xu K, Shi Z, Veeck L, Hughes M, Rosenwaks Z. First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia. Journal of American Medical Association 281(18):1701-06, 1999.

Yaron Y, Bryant-Greenwood PK, Dave N, Moldenhauer JS, Johnson KD, Johnson MP, Evans MI. Multifetal pregnancy reduction (MFPR) of triplets to twins: Comparison with non-reduced triplets and twins. American Journal of Obstetrics and Gynecology 180(5):1268-71, 1999.

Yaron Y, Cherry M, OÕBrien JE, Hallak M, Johnson MP, Evans MI. Second trimester maternal serum marker screening: MSAFP, B-hCG, estriol, and their various combinations as predictors of pregnancy outcome. American Journal of Obstetrics and Gynecology 181(4):968-974, 1999.

Yaron Y, Hassan S, Kupferminc MJ, Geva E, Yavetz H, Evans MI. The evaluation of fetal echogenic bowel in the second trimester. Fetal Diagnosis and Therapy 14(3):176-180, 1999.

Yaron Y, Rotter V, Aloni R, Schwartz D, Evans MI. Expression of the p53 tumor suppressor gene in the mouse ovary during an artificially induced ovulatory cycle. Journal of Reproductive Medicine (in press).

Books, Chapters and Reviews

Bui TH, Jaffe R, Lindholm H, Evans MI. Fetal Spine Defects. In: Obstetric Ultrasonography: A Clinical Guide, (R Jaffe, TH Bui, eds.), Parthenon Publishing, London. pp.199-216, 1999.

Buttino L Jr., Evans MI, Sibai BM (eds). Study Guide for Principles and Practices of Medical Therapy in Pregnancy, 3rd Edition. Appleton and Lange Publishing Co., Norwalk, 1999.

Dommergues M, Aubry MC, Mahieu-Ceputo D, Evans MI, Dumez Y. Multifetal Pregnancy Reduction and Selective Termination. In: Fetal Medicine: Basic Science and Clinical Practice, (CH Rodeck, MJ Whittle, M Ferguson, M Hanson, S Bewley, R Nelson, W Holzgreve, MI Evans, B Benacerraf, B Trudinger, M Chiswick, eds.), Churchill Livingston, London, pp 879-886, 1999.

Drugan A, et al. Classic Genetic Principles. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Drugan A, et al. Traditional Amniocentesis. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Drugan A, Feldman B, Johnson MP, Evans MI. Prenatal Diagnosis: Procedures and Trends. In: Neonatology: Pathophysiology and Management of the Newborn, 5th Edition, (GB Avery, M MacDonald, MA Fletcher, eds.), Lippincott Williams & Wilkins, Philadelphia. pp. 161-171, 1999.

Evans MI. Genetic Counseling, Screening, Diagnosis, and Fetal Therapy (Review). Philippine Journal of Obstetrics and Gynecology (in press).

Evans MI. Metabolic Therapy. In: Fetal Therapy, (MI Evans, LD Platt, F de la Cruz, eds.), Parthenon Publishing, London (in press).

Evans MI (ed). Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management. Appleton and Lange, Norwalk, (in press).

Evans MI. Screening for Aneuploidy (Review). Current Opinion in Obstetrics and Gynecology 11(2):115-18, 1999.

Evans MI. Techniques for Hematopoietic Stem Cell Transfer. In: Diagnosis and Treatment of the Unborn Child, (M New, ed.), Idelson-Gnocchi Ltd. Reddick, Florida, pp.137-139, 1999.

Evans MI, et al. Biochemical Screening. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Evans MI, et al. Fetal Muscle Biopsy. In: Diagnostic and Operative Fetoscopy, (RA Quintero, ed.), Parthenon Publishing, New York (in press).

Evans MI, et al. Fetal Therapy and Fetal Surgery. In: Obstetrics: Normal and Problem Pregnancies, 4th Edition, (SG Gabbe, JR Niebyl, JL Simpson, eds.), WB Saunders, New York (in press).

Evans MI, et al. Tissue biopsies. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Evans MI, Dvorin E, Bui TH, OÕBrien JE. Biochemical Screening for Aneuploidy. In: Gynecology and Obstetrics, (J Sciarra, ed.), Lippincott Raven, Philadelphia (in press).

Evans MI, Evans WJ, Johnson MP. Ethics of Reproduction. In: WomenÕs Studies Encyclopedia, (Tierney H, ed.), Greenwood Publishing, Westport, Connecticut. pp. 1206-1221, 1999.

Evans MI, Flake AW, Johnson MP, Belkin HR, Johnson A, Harrison M. In Utero Treatment: State of the Art. In: Fetal Medicine: The Clinical Care of the Fetus as a Patient, (F Chervenak, A Kurjak, eds.), Parthenon Publishing, London, pp.186-204, 1999.

Evans MI, Ginsburg KA (eds). Pretest: Obstetrics and Gynecology, 9th Edition. McGraw-Hill, New York (in press).

Evans MI, Harrison M, Johnson MP, Feldman B, Holzgreve W. Fetal Therapy. In: Neonatology: Pathophysiology and Management of the Newborn, 5th Edition, (GB Avery, M MacDonald, MA Fletcher, eds.), Lippincott Williams & Wilkins, Philadelphia. pp. 173-185, 1999.

Evans MI, Henry G, Miller W, Bui T, Snijders R, Wapner R, Miny P, Johnson M, Peakman D, Johnson A, Nicolaides K, Holzgreve W, Ebrahim S, Jackson L. Letter to the Editor. Human Reproduction (in press).

Evans MI, Hume RF, Lewis P, Feldman B, Yaron Y. Pharmacologic Fetal Therapy. In: Ultrasound and Fetal Therapy, (MI Evans, CH Rodeck, eds.), Parthenon Publishing, London, pp. 95-104, 1999.

Evans MI, Hume RF, Yaron Y, Kramer RL, Johnson MP. Reduction of High Multiple Pregnancies. In: Clinical Obstetrics and Gynecology, (B Neilson, JP Ballieres, eds.) JB Lippincott, Philadelphia, pp. 147-159, 1999.

Evans MI, Johnson A, Gilbert AD. The Future of Chromosome Screening: Ultrasound, Biochemistry, or Both (Review). Frontiers in Fetal Health: A Global Perspective 1(1):16, 1999.

Evans MI, Johnson MP. Genetics and Prenatal Diagnosis. In: Practical Strategies in Obstetrics and Gynecology, (MP Dombrowski, SB Ransom, SG McNeeley, MP Diamond, AR Munkarah, eds.), WB Saunders, Philadelphia (in press).

Evans MI, Johnson MP. Multifetal Pregnancy Reduction. In: Medicine of the Fetus and Mother, 2nd Edition, (EA Reece, J Hobbins, eds), Lippincott/Raven, Philadelphia, pp. 1433-1438, 1999.

Evans MI, Johnson MP. Multifetal Pregnancy Reduction and Selective Termination. In: High Risk Pregnancy: Management Options, (DK James, PJ Star, CP Weiner, B Gonik, eds.), WB Saunders, London, pp. 243-248, 1999.

Evans MI, King M, Hoffman E, Holzgreve W. Fetal Tissue Biopsies. In: High Risk Pregnancy: Management Options, (DK James, PJ Star, CP Weiner, B Gonik, eds.), WB Saunders, London, pp. 235-241, 1999.

Evans MI, Krivchenia EL, King M, Hoffman E. Muscular Dystrophy. In: Fetal Medicine: Basic Science and Clinical Practice, (CH Rodeck, MJ Whittle, M Ferguson, M Hanson, S Bewley, R Nelson, W Holzgreve, MI Evans, B Benacerraf, B Trudinger, M Chiswick, eds.), Churchill Livingston, London, pp. 519-524, 1999.

Evans MI, Levy, H. The Future of Newborn Screening Belongs to Obstetricians (Review). Acta Paediatric Supplement. 88(432):55-57, 1999.

Evans MI, O'Brien JE, Dvorin E, Critchfield G. Screening for Aneuploidy. In: Management of High Risk Pregnancy, 4th Edition, (JJ Queenan, ed.), Blackwell Science, Malden, Massachusetts, pp. 119-135, 1999.

Evans MI, O'Brien JE, Johnson A. Screening for Aneuploidy. In: Current Opinion in Obstetrics and Gynecology. Lippincott, Williams & Wilkins, London, pp. 115-118, 1999.

Evans MI, Platt LD, de la Cruz F (eds). Fetal Therapy. Parthenon Publishing, London (in press).

Evans MI, Rodeck CH (eds). Ultrasound and Fetal Therapy. Parthenon Publishing, London, (in press).

Evans MI, Rodeck CH, et al. Selective Termination. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Evans MI, Rodeck CH, Holzgreve W, et al. CVS. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Evans MI, Yaron Y, Kramer RL, Johnson MP. Options Following the Diagnosis of a Fetal Anomaly. In: Prenatal Care: Effectiveness and Implementation, (MC McCormick, ed.), Cambridge University Press, Cambridge, England, pp. 244-258, 1999.

Evans MI, Yaron Y, Lewis P, Hume RF. Fetal Pharmacologic Therapy. In: Textbook of Perinatal Medicine, (A Kurjak, K Nicolaides, et al, eds), Parthenon Publishing, London, pp. 1065-1072, 1999.

Evans MI, Yaron Y, Littmann L, Tapin C, Belkin HR. Issues in Multifetal Pregnancy Reduction. In: Fetal Medicine: The Clinical Care of the Fetus as a Patient, (F Chervenak, A Kurjak, eds.), Parthenon Publishing, London, pp. 136-150, 1999.

Evans WJ, et al. Sociological Issues. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Flake AW. Fetal Saccro Coccygeal Teratomas. In: Ultrasound and Fetal Therapy, (MI Evans, CH Rodeck, eds.), Parthenon Publishing, London, pp. 39-48, 1999.

Isada NB, Martin LS, Evans MI. Prenatal Diagnosis in the Molecular Age. In: Neonatology: Pathophysiology and Management of the Newborn, 5th Edition, (GB Avery, M MacDonald, MA Fletcher, eds.), Lippincott Williams & Wilkins, Philadelphia. pp. 111-123, 1999.

Harrison MR, Evans MI, Adzick NS, Holzgreve W (eds). The Unborn Patient: The Art and Science of Fetal Therapy, 3rd Edition. WB Saunders, Philadelphia (in press).

Holzgreve W, Tercanli S, Evans MI, Miny P. Placental Biopsies for Rapid Karyotyping in the Second and Third Trimesters (Late CVS) in High Risk Pregnancies. In: Prenatal Diagnosis and Fetal Treatment, (AJ Antsaklis, ed.), Greece (in press).

Hughes MR, et al. Preimplantation Diagnosis. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Johnson MP. Obstructive Uropathies. In: Fetal Therapy, (MI Evans, LD Platt, F de la Cruz, eds.), Parthenon Publishing, London (in press).

Johnson MP, et al. Cytogenetic Disorders. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Johnson MP, et al. Fetal Surgery - Shunts. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Johnson MP, et al. Lower Urinary Tract Assessment. In: Diagnostic and Operative Fetoscopy, (RA Quintero, ed.), Parthenon Publishing, New York (in press).

Johnson MP, Feldman B, Evans MI. Fetal Shunt Procedures. In: Ultrasound and Fetal Therapy, (MI Evans, CH Rodeck, eds.), Parthenon Publishing, London, pp. 1-18, 1999.

Kramer RL, et al. Chemotherapy. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Kramer RL, et al. New Genetic Concepts. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Krivchenia EL, et al. Genetic Counseling. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Lewis P, Yaron Y, Evans MI. Diagnosis and treatment of fetal endocrine disorders. In: Fetal Medicine: Basic Science and Clinical Practice, (CH Rodeck, MJ Whittle, M Ferguson, M Hanson, S Bewley, R Nelson, W Holzgreve, MI Evans, B Benacerraf, B Trudinger, M Chiswick, eds.), Churchill Livingston, London, pp. 829-834, 1999.

Ransom SB, Dombrowski MP, Evans MI (eds). Contemporary Therapy in Obstetrics and Gynecology. WB Saunders, Philadelphia (in press).

Rodeck CH, Whittle MJ, Ferguson M, Hanson M, Bewley S, Nelson R, Holzgreve W, Evans MI, Benacerraf B, Trudinger B, Chiswick M (eds). Fetal Medicine: Basic Science and Clinical Practice. Churchill Livingstone, London, 1999.

Stewart K, Yaron Y. Radiation. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Treadwell M, Johnson MP, et al. GU. In: Prenatal Diagnosis: Genetics, Reproductive Risks, Testing, and Management, (MI Evans, ed.), Appleton and Lange, Norwark (in press).

Yaron Y, Evans MI. Fetal Metabolic and Gene Therapy. In: Medicine of the Fetus and Mother, 2nd Edition, (EA Reece, J Hobbins, eds), Lippincott/Raven, Philadelphia, pp. 873-890, 1999.

Yaron Y, Flake AW, Johnson MP, Evans MI. Fetal stem cell and gene therapy. In: Textbook of Perinatal Medicine, (Kurjak A, Nicolaides K, et al, eds). Parthenon Publishing, London, pp. 1093-1103, 1999

Yaron Y, Flake AW, Zanjani E, Johnson MP, Evans MI. Stem Cell Fetal Therapy. In: Ultrasound and Fetal Therapy, (MI Evans, CH Rodeck, eds.), Parthenon Publishing, London, pp. 105-112, 1999.

Abstracts, Letters to the Editor, Articles in Non-Refereed Journals

Baker C, Feldman B, Shalhoub AG, Ayoub MA, Evans MI. Demographic determinants on the utilization of invasive genetic testing after multifetal pregnancy reduction (MFPR). Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Bianchi DW, Simpson JL, Jackson LG, Evans MI, Elias S, Holzgreve W, Sullivan L, Cruz F, DM-STAT on behalf of the NICHD Fetal Cell Study (NIFTY) Group (Letter to the editor). Prenatal Diagnosis 19(10):994-995, 1999.

Carreno CA, Yaron Y, Feldman B, Treadwell M, Johnson MP, Ayoub MA, Evans MI. First trimester embryo size discordancy: A predictor of prematurity following multifetal pregnancy reduction (MFPR). Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S104, 1999.

Chik L, Chik K, Spencer K, Sokol RJ, Krantz D, Johnson A, Macri JN, Evans MI. An evaluation of likelihood ratios for Down syndrome from maternal age, alpha-fetoprotein, and free beta human chorionic gonadotrophin. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology (in press).

Chik L, Spencer K, OÕBrien JE, Sokol R, Macri J, Pandian R, Evans MI. Disparities in risk estimates for Down syndrome (DS) in biochemical screening: A comparison of methods on decision cut-points. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation 6:99A, 1999.

de la Cruz F, Shifrin H, Elias S, Bianchi DW, Jackson L, Evans MI, Simpson JL, Holzgreve W, Klinger K. Low false positive rates of aneuploidy detection using fetal cells isolated from maternal blood. Fetal Diagnosis and Therapy 13(6):380, 1999.

Drugan A, Avrahami R, Zamir R, Itskovitz-Eldor J, Sokol RJ, Evans MI. Fetal gender impact on incidence and implications of sonographic markers for Down syndrome (SMDS). Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S172, 1999.

Drugan A, Feldman B, Ebrahim SAD, Johnson MP, Krivchenia EL, Kasperski S, Evans MI. Differential impact of age, ultrasound, and biochemical screening on aneuploid detection. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation 6:99A, 1999.

Evans MI. Editorial. Current Opinion in Obstetrics and Gynecology 11:13-14, 1999.

Evans MI. Overview of Fetal Therapy. In: Diagnosis and Treatment of the Unborn Child, (M New, ed.), Idelson-Gnocchi Ltd., Reddick, Florida, pp.133-136, 1999.

Evans MI, Ayoub MA, Shalhoub AGG, Feldman B, Yaron Y, Johnson A. 35% of couples declining multifetal pregnancy reduction spontaneously abort. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Evans MI, Carpenter R, Goldberg JD, Johnson A, Nicolaides K, Holzgreve W, Berkowitz RL, Timor-Tritsch I, Wapner RJ. Collaborative multifetal pregnancy outcomes (MFPR): Outcomes and fetal growth. International Fetal Medicine and Surgery Society, 1999.

Evans MI, Elias S, Bianchi D, Jackson L, Holzgreve W, de la Cruz F, Wapner RJ, Dukes KA, Klinger K, Krivchenia EL, Simpson JL. Racial/ethnic confounders to the detection of Y signals in maternal blood in women carrying male fetuses: The NIFTY Group Study. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Evans MI, Goldberg J, Ayoub MA, Liptz S, Johnson A, Berkowitz R. Second trimester selective termination update. International Fetal Medicine and Surgery Society, 1999.

Evans MI, Goldberg J, Horenstein J, Wapner R, Ayoub MA, Stone J, Lipitz S, Achiron R, Holzgreve W, Brambati B, Johnson A, Johnson MP, Berkowitz R. Selective termination (ST) for structural (STR), chromosomal CHR), and Mendelian (MEN) anomalies: International experience. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S31, 1999.

Evans MI, Nicolaides K, Goldberg JD, Wapner RJ, Horenstein J, Dommergues M, Holzgreve W, Timor-Tritsch I, Carpenter R, Baker C, Ayoub M, Shaloub A, Brambati B, Snijders R, Monteagudo A, Berkowitz R. Birth weight discordancy among remaining fetuses after multifetal pregnacy reduction (MFPR) and selective termination: Correlation with starting number. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation 6:5A, 1999.

Evans MI, Wapner R, Carpenter R, Goldberg J, Timor-Tritsch IE, Ayoub MA, Stone J, Horenstein J, Snijders R, Dommergues M, Brambati B, Nicolaides K, Holzgreve W, Tuliu L, Lerner J, Dumez Y, Monteagudo A, Johnson MP, Berkowitz R. International collaboration on multifetal pregnancy reduction (MFPR): Dramatically improved outcomes with increased experience. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S28, 1999.

Evans MI, Wapner RJ, Timor-Tritsch I, Carpenter R, Goldberg JD, Nicolaides K, Dommergues M, Dumez Y, Horenstein J, Stone J, Ayoub M, Shalhoub A, Baker C, Monteagudo A, Snijders R, Berkowitz R. Methods of initiation of multifetal pregnancies: Implications for outcomes following multifetal pregnancy reduction. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation 6:213A, 1999.

Feldman B, Dotson LK, Johnson MP, Johnson A, Evans MI. A comparison of misoprostol with carboprost for induction of second-trimester genetic termination of pregnancy. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Feldman B, Ebrahim SAD, Gyi K, Ayoub MA, Johnson MP, Dombrowski MP, Evans MI. Utilization of fluorescent in situ hybridization for diagnosis of abnormal fetal karyotypes other than aneuploidy. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S57, 1999.

Feldman B, Ebrahim SAD, Gyi K, Johnson A, Johnson MP, Evans MI. Routine prenatal diagnosis of aneuploidy by FISH studies in high risk pregnancies. International Fetal Medicine and Surgery Society, 1999.

Feldman B, Hazan SL, Ebrahim SAD, Krivchenia EL, Drugan A, Johnson MP, Evans MI. Pregnancy outcomes of confined placental mosaicism Ð A 10 year study. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S56, 1999.

Feldman B, Hazan SL, Ebrahim SAD, Krivchenia EL, Johnson MP, Evans MI. Pseudomosaicism from maternal cell contamination is much more prevelent with cytogenetically abnormal fetuses. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S56, 1999.

Feldman B, Jacques SM, Qureshi F, Johnson MP, Johnson A, Evans MI. Postabortion pathologic analysis is hampered by pretreatment induction of fetal cardiac asystole. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology (in press).

Feldman B, Qureshi F, Jacques SM, Cefalu MJV, Moran O, Shalhoub AG, Johnson M, Evans MI. Pathologic analysis of fetal specimens from dilatation and evacuation (D&E), for second trimester genetic termination of pregnancy - A 5 year study. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Johnson A, Abella EM, Kukuruga DL, Whitten-Shurney W, Baynes RD, Lyman WD, Whitten CF, Evans MI. In-utero transplantation of paternal CD34 enriched T-cell depleted hematopoietic stem cells for treatment of sickle cell anemia. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Johnson MP, Feldman B, Kasperski S, Qureshi F, Jacques S, Gonzalez R, Evans MI. Prenatal evaluation and shunting for fetal obstructive uropathy: Management of nearly 100 cases. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S30, 1999.

Johnson A, Leach R, Johnson MP, Lee H, Qureshi F, Hassan S, Romero R, Evans MI. Selective termination using bipolar cautery: The Detroit experience. International Fetal Medicine and Surgery Society, 1999.

Johnson A, Leach R, Lee HM, Richter R, Qureshi F, Jacques SM, Romero R, Hassan S, Sokol RJ, Evans MI. Bipolar coagulation (BPF): An improved method of selective termination in complicated monochorionic twin pregnancies. Central Association of Obstetricians and Gynecologists, 1999.

Johnson MP, Romero R, Edwin SS, Feldman B, Kasperski S, Qureshi F, Evans MI. Evidence for differential expression of growth factors and cytokinse in the urine of fetuses with obstructive uropathy. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S11, 1999.

Johnson A, Tyagi R, Gilbert AD, Stockman PT, Bawle E, Evans MI, Treadwell MC, Zador IE. Perinatal outcome in prenatally diagnosed situs inversus. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology (in press).

Kramer RL, Comeaux TY, Kowalczyk CL, Yaron Y, Feldman B, Johnson MP, Evans MI. Ovulation induction influences maternal serum markers for Down syndrome and neural tube defects. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180, 1999.

Kramer RL, OÕBrien JE, Dombrowski MP, Drugan A, Feldman B, Ayoub MA, Evans MI. Insufficient power to verify the accuracy of risk predictions in biochemical screening even in the worldÕs largest databases. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation 6:99A, 1999.

Lewis D, Bischoff, Simpson JL, Elias S, Bianchi D, Klinger K, Dukes K, Sullivan L, Evans M, Holzgreve W, Hahn S, Jackson L, Wapner R, de la Cruz F, Shifrin H. Multicenter study of fetal cell recovery from maternal circulation and analysis. American Society of Human Genetics, 1999.

Miller V, Ransom SB, Ayoub MA, Krivchenia EL, Evans MI. The fiscal impact of a potential legislative ban on second trimester medically indicated abortions. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S57, 1999.

Miller VL, Ransom SB, Shalhoub A, Sokol RJ, Evans MI. Multifetal Pregnancy reduction: perinatal and fiscal outcomes. Central Association of Obstetricians and Gynecologists, 1999.

Ochshorn Y, Jaffa AJ, Evans MI, Orr-Urtreger A, Many A, Lessing JB, Yaron Y. ROC-curve-derived lower cutoff for first trioemster PAPP-A: Increasing sensitivity for non-Down Syndrome aneuploidy detection. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Ransom SB, Mickelson IH, Makela PR, Essenmacher L, Evans MI. The quality of cost-effectiveness and cost-benefit analyses in the obstetrics and gynecology literature. Central Association of Obstetricians and Gynecologists, 1999.

Reddy U, Ayoub MA, Evans MI, Wapner RJ . Multiple gestations: Ultrasound diagnosis of trisomy 21. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S167, 1999.

Seubert DE, Feldman B, Krivchenia El, Evans MI, Barki J, Johnson MP. Molecular and fetal tissue biopsy capabilities are needed to maximize prenatal diagnosis of junctional epidermolysis bullosa (JEB): Fetal skin biopsy using a 2mm microendoscope. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S182, 1999.

Sokol AI, Kramer RL, Yaron Y, OÕBrien JE, Muller F, Johnson MP, Evans MI. Letter to the Editor. American Journal of Obstetrics and Gynecology 180(6):1598, 1999.

Sukkar N, Flore LA, Mohamed A, Ebrahim S, Evans M, Johnson A. Detection of a De Novo unbalanced cryptic 6;21 translocation by fluorescence in situ hybridization (FISH) in a fetus with multiple congenital anomalies. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation (in press).

Yaron Y, Jaffa AJ, Har-Toov Y, Amster R, Gull I, Wolman I, Avrashi S, Lessing JB, Evans MI. First trimester combined screening using nuchal translucency and maternal serum PAPP-A and free $-hCG in the detection of chromosomal anomalies. Society for Gynecologic Investigation/Journal of the Society for Gynecologic Investigation 6:100A, 1999.

Yaron Y, Krivchenia EL, Cole LA, Leon J, Bradford S, Hallak M, Evans MI. Urinary b-core fragment (BCF) of human chorionic gonadotropin (hCG) as a predictor of Down syndrome (DS): Comparison with triple serum marker screening. Society for Maternal Fetal Medicine/American Journal of Obstetrics and Gynecology 180:S57, 1999.

Back to Obstetrics and Gynecology